Original articleMiR-670-5p induces cell proliferation in hepatocellular carcinoma by targeting PROX1
Introduction
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with highest incidence, especially in Asia [1]. The high mortality is mainly attributed to a result of rapid progression and a lack of effective therapies. Although the surgical removal of the tumor is considered as the better means for treating HCC, it also bring out negative effects after operation. Therefore, study of the molecular mechanisms that control progression of HCC is important for the development of new therapeutic strategies.
MicroRNAs (miRNAs) are endogenous and small RNA moleculars that play critical roles in post-transcriptional regulation by directly targetting mRNAs [2]. A number of miRNAs has been demonstrated to altered express in the occurrence and development of various human cancers, including HCC. miR-199a-5p was observed to be significantly down-regulated in HCC tissues and cell lines [3]. miR-122, as a liver-specific miRNA, is proved to impacts cell differentiation, proliferation, metabolism, stress and other liver processes by regulating the expression of a large
number of target genes [4], [5], [6]. miRNA-433 was down-regulated in HCC tissues and cells and overexpression of miRNA-433 significantly suppressed the proliferation through restoring PI3K/AKT signaling in HepG2 cells [7]. miR-744 was also down-regulated in tissues and cells related to HCC and restoration of miR-744 decreased cell growth and restored G1 accumulation [8]. However, little has been carried out to identify the potential roles of miR-670-5p in HCC. Thus in present study, we detected miR-670-5p in HCC specimens and in hepatoma-derived cells. Apart from the expression in HCC, the functional effect of miR-670-5p was also detected in vitro. Our results showed that miR-670-5p was elevated in HCC and could modulate cell proliferation. A transcription factor PROX1 was identified as a target of miR-670-5p in HCC. Furthermore, the PROX1 expression was repressed by miR-670-5p and this posttranscriptional regulation may be important in enhancing proliferation activity that is associated with HCC.
Section snippets
Patient samples
28 patients had been diagnosed with HCC and underwent resection at Shandong Jining NO.1 People’s Hospital from 2012 to 2014. The paired adjacent non-cancerous tissues (NT) were obtained as control. All patients were informed consent by the Research Ethics Boards of the hospital. The surgical samples were snap frozen in liquid nitrogen immediately after resection for preparing to extract total RNA.
Cell culture
Human normal liver cell lines L02 and human HCC cell lines Hep3B were were obtained from the Cell
Expression of miR-670-5p was upregulated in HCC
To detect the abnormal expression of miR-670-5p in HCC specimens, qRT-PCR was used to analyze 28 pairs of HCC tissues and adjacent non-tumor tissues (NT). As shown in Fig. 1A and B, except for one pair of specimens, expression of miR-670-5p was significantly upregulated in 27HCC tissues compared with NT. Furthermore, at least 60% of HCC tissues showed a greater than three-fold enhance in the expression of miR-670-5p compared with NT. We also evaluated the expression of miR-670-5p In HCC cell
Dicussion
miRNA has been shown to be aberrantly expressed function as a tumor suppressor gene or oncogene according to developmental stage, organ, or type of cancer. In HCC, miR-17-92 cluster and miR-106b-25 cluster are over-expression [9]. miR-221 was up-regulated in HCC and was associated with higher tumor stage. Furthermore, it was proved to promote the development of tumor in a transgenic mouse model [10]. miR-9 expression was up-regulated in HCC tissues compared with normal control. The raise of
Conclusion
In present study, our data indicate the potential of miR-670-5p as a novel biomarker for HCC. miR-670-5p was high expressed in HCC tissues and cells. PROX1 which was decreased in HCC was confirmed as a direct tatget of miR-670-5p. Both knokdown of miR-670-5p and overexpression of PROX1 could inhibit cellular proliferation, inferring that miR-670-5p may enhance proliferation activity that is associated with HCC by modulating PROX1expression. Therefore, miR-670-5p may play a tumor-promoted role
Acknowledgements
The present work was supported by Science and Technology Development Plan Project of Jining Traditional Chinese Medicine (No. LC2012016) and Teaching Reformation Project of Jining Medical University (No. 14010).
Reference: (22)
MicroRNAs: target recognition and regulatory functions
Cell
(2009)- et al.
Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system
J. Hepatol.
(2007) - et al.
Loss of function of the candidate tumor suppressor prox1 by RNA mutation in human cancer cells
Neoplasia
(2006) - et al.
Natural history of hepatitis-related hepatocellular carcinoma
World J. Gastroenterol.
(2008) - et al.
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion
Mol. Cancer
(2015) - et al.
MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
Hepatology
(2009) - et al.
miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3
Oncol. Rep.
(2011) - et al.
MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA
PloS ONE
(2014) - et al.
MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4)
Mol. Cell. Biochem.
(2014) - et al.
Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma
Cancer Cell Int.
(2014)